BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment
Clinical trial NCT04932863 · COMPLETED
Trial details
- NCT number
- NCT04932863
- Sponsor
- Ente Ospedaliero Ospedali Galliera
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-03-15
- Primary completion
- 2022-03-15
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.